• Pollen Interference in Hazardous Aerosol Detection

  2026-08-23

  The reference study shows that pollen can distort excitation–emission matrix fluorescence classification of hazardous bioaerosols, but feature transformation can substantially reduce this interference. Combining preprocessing, fast Fourier transform analysis, and random forest classification produced 89.24% accuracy across 31 sample types and separated several important bacterial and toxin signals.

• DRD4, PI3K/Akt Signaling, and Liver Cancer Stemness

  2026-08-22

  The reference study identifies DRD4 as an upstream regulator of liver cancer stem cell-like behavior, linking dopamine-receptor activity to PI3K/Akt/GSK-3β-dependent β-catenin stabilization and nuclear translocation. Its integrated molecular, clinical, pharmacological, and gene-editing approach provides a framework for studying chemotherapy resistance while clarifying why pathway-level validation is needed before translating these findings into PI3K-targeted workflows.

• Sulfo-NHS-Biotin for Nanovial Cell Assays

  2026-08-21

  Sulfo-NHS-Biotin combines membrane-impermeant cell-surface labeling with aqueous, amine-selective chemistry. Used alongside capped nanovials, it can help connect molecular identity to single-cell growth, secretion, and interaction phenotypes while preserving standard wash, imaging, and flow-cytometry workflows.

• Lyso-Tracker Red for Reliable Lysosome Assays

  2026-08-21

  Learn how Lyso-Tracker Red, SKU B8814, supports reproducible lysosome labeling in live-cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers assay compatibility, protocol control, interpretation, and practical vendor selection.

• Substance P Workflows for Neuroimmune Assays

  2026-08-20

  Build more reproducible Substance P experiments by connecting NK-1 receptor biology with disciplined peptide handling, dose design, and spectral quality control. This workflow also adapts an interference-resistant fluorescence strategy for laboratories studying pain transmission research, inflammation, and immune response modulation.

• Lypressin acetate: Reliable Cell Assays

  2026-08-20

  This scenario-based guide explains how Lypressin acetate (SKU N2888) can be incorporated into cell viability, proliferation, cytotoxicity, and receptor-signaling workflows. It connects receptor pharmacology, quantified bioactivity, storage practice, and vendor qualification to help researchers design more interpretable and reproducible experiments.

• Penicillin G Sodium in Barrier-Infection Assays

  2026-08-19

  Penicillin G Sodium is a natural penicillin antibiotic whose antibacterial activity can materially influence infection and epithelial-barrier experiments. This guide separates bacterial killing from inflammation biology and translates a recent intestinal-barrier study into better assay controls and interpretation.

• Digoxin: Na+/K+-ATPase Inhibition in Research

  2026-08-19

  Digoxin is a cardiac glycoside and Na+/K+ ATPase pump inhibitor used to study cardiac contractility modulation, arrhythmia biology, and cell-type-specific chikungunya virus inhibition. Its strongest research utility is mechanistic: it links sodium-potassium transport to intracellular calcium handling, while antiviral findings remain limited to defined cell-based conditions.

• Pollen Interference in EEM Substance Classification

  2026-08-18

  The 2024 Molecules study shows that pollen can distort excitation–emission matrix fluorescence profiles used to classify hazardous bioaerosols. Combining spectral transformations, particularly fast Fourier transform processing, with random forest classification improved recognition and helped distinguish several important bacterial and toxin targets.

• Dextromethorphan Hydrobromide: Assay Logic

  2026-08-18

  Dextromethorphan hydrobromide is a mechanistic probe for NMDA receptor antagonist and ion-channel studies. This article presents an evidence-based framework for separating target engagement, excitotoxicity inhibition, and genuine neuroprotection in translational assays.

• Ganoderma Polysaccharide Enhances mRNA-LNP Efficacy

  2026-08-17

  The reference study identifies Ganoderma lucidum polysaccharide (GLP) as an adjuvant that improves mRNA-LNP performance while reducing oxidative stress. Its findings connect redox regulation, Nrf2 pathway activity, and higher protein expression, suggesting a complementary strategy to lipid and polymer redesign.

• GCRV Entry and the Limits of Latrunculin B

  2026-08-17

  Wang et al. used pharmacological inhibitors, transmission electron microscopy, and real-time quantitative PCR to define how genotype III grass carp reovirus enters CIK cells. The study identified a dynamin-dependent, acidification-dependent clathrin pathway and showed that Latrunculin B did not block infection under the tested conditions, an important boundary for interpreting actin-related entry mechanisms.

• ASCH Proteins and N4-Acetylcytidine Processing

  2026-08-16

  Meng et al. define how the ASCH-domain protein EcYqfB hydrolyzes free N4-acetylcytidine into cytidine while showing that it does not remove ac4C from RNA. Structural comparisons with mouse EOLA1 and the human TRIP4-ASCH domain separate nucleoside processing from RNA modification turnover and provide a framework for better nucleotide processing enzyme assays.

• Icatibant in Viral Infections: Evidence and Limits

  2026-08-15

  This reference letter frames icatibant as a mechanism-guided intervention for severe viral disease in which bradykinin-driven vascular permeability contributes to hypotension, edema, and organ injury. Its key contribution is translational rather than definitive: case observations in Puumala hantavirus infection, together with a cited COVID-19 trial, support early investigation while leaving efficacy in hantavirus disease unproven.

• 2',7'-Dichlorofluorescein diacetate ROS Workflow

  2026-08-14

  Turn a broadly responsive redox dye into a controlled intracellular ROS measurement workflow for microscopy, flow cytometry, and plate assays. The approach translates findings from a ROS-responsive pancreatic cancer nanocarrier study into practical controls, assay conditions, and interpretation safeguards.

8063 records 1/538 page Next 12345 下5页 Last page